rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-8-2
|
pubmed:abstractText |
The objective of this investigation was to establish the safety of high-dose (HD) acyclovir for the treatment of neonatal herpes simplex virus (HSV) disease. In addition, an estimate of therapeutic efficacy was sought, both with respect to mortality and to morbidity. Virologic efficacy of HD acyclovir was also assessed.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1098-4275
|
pubmed:author |
pubmed-author:ArvinA MAM,
pubmed-author:BradleyJ SJS,
pubmed-author:CoreyLL,
pubmed-author:DiazP SPS,
pubmed-author:GruberW CWC,
pubmed-author:GutierrezKK,
pubmed-author:JacobsR FRF,
pubmed-author:KiellJJ,
pubmed-author:KimberlinD WDW,
pubmed-author:KumarMM,
pubmed-author:LakemanF DFD,
pubmed-author:LinC YCY,
pubmed-author:National Institute of Allergy and Infectious Diseases Collaborative...,
pubmed-author:PowellD ADA,
pubmed-author:RathoreMM,
pubmed-author:SheltonMM,
pubmed-author:SleasmanJ WJW,
pubmed-author:SoongS JSJ,
pubmed-author:WeinerL BLB,
pubmed-author:WellerSS,
pubmed-author:WhitleyR JRJ,
pubmed-author:de SierraT MTM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
230-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
|
pubmed:year |
2001
|
pubmed:articleTitle |
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
|
pubmed:affiliation |
Department of Pediatrics, University of Alabama at Birmingham, Alabama 35233, USA. dkimberlin@peds.uab.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|